• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Altcoins Gain Momentum amid Bitcoin's Declining Share

user avatar

by Giorgi Kostiuk

a year ago


With Bitcoin's dominance declining, the altcoin market is experiencing a boost. Terra Classic and Compound stand out with their impressive weekly performances.

Terra Classic (LUNC)

LUNC recently broke out from a descending triangle pattern it was trapped in for over two years. After breaching the descending resistance line at $0.0001262, the token surged to $0.0001442 before pulling back to retest its breakout level. Currently, LUNC trades around $0.0001317. If it reverses from the current level and reclaims $0.0001442, it could ignite a new rally, targeting the next resistance levels at $0.00026 and $0.00033.

Compound (COMP)

Compound also managed to break out of a long-standing descending triangle, starting from $75.50. After reaching $80.76, COMP returned to its breakout zone and is trading near $76.80. If COMP manages to rise above $81.67, a new rally could ensue, targeting $102.76. A sustained move could see COMP reaching as high as $174, representing a 126% increase from current levels.

Final Thoughts

With successful retests, LUNC and COMP demonstrate potential for significant gains. As Bitcoin's dominance wanes, the altcoin market is gaining renewed strength, offering exciting opportunities for traders.

With successful retests, LUNC and COMP hold potential for further rises. As Bitcoin dominance decreases, the altcoin market gains new strength, presenting exciting opportunities for traders.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

BioAge Labs Focuses on Metabolic Aging with AI

chest

BioAge Labs is utilizing machine learning to explore metabolic aging and develop treatments for metabolic disorders.

user avatarAyman Ben Youssef

Neumora Therapeutics Targets Brain Diseases with AI

chest

Neumora Therapeutics is developing AI-driven solutions for treating brain diseases, including schizophrenia and Alzheimer's.

user avatarSon Min-ho

Relay Therapeutics Innovates Drug Discovery with AI

chest

Relay Therapeutics is using its AI-powered platform to enhance drug discovery processes in oncology.

user avatarJacob Williams

AI Advances in Biotech: Nobel Prize Winners and Promising Companies

chest

In 2024, the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their groundbreaking work in using machine learning to design entirely new proteins, highlighting the growing role of AI in biotech.

user avatarTando Nkube

OBBBA Law Restores R&D Deductions for Biotech Companies

chest

The One Big Beautiful Bill Act restores 100% deduction of R&D expenses for biotech companies, aimed at revitalizing domestic industries and reducing financial pressure.

user avatarZainab Kamara

Launch of OTCfi Token on Olympus Chain

chest

Launch of OTCfi Token on Olympus Chain as part of the partnership between Metavesco and BLAQclouds, aimed at expanding utility in crypto and OTC markets.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.